Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, encouraging development where profits are low. Learn how it works, why it matters, and who benefits.
GDUFA laws let the FDA collect fees from generic drug makers to speed up approvals, reduce backlogs, and ensure safe, affordable medicines reach patients faster. Here's how it works and why it matters.
Diarex helps with diarrhea, but it's not always the best choice. Learn how loperamide, bismuth subsalicylate, probiotics, and ORS compare - and which option is safest and most effective for your situation.
© 2025. All rights reserved.